Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01774851
Title A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Merrimack Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Birmingham Alabama 35294 United States Details
Los Angeles California 90089 United States Details
Los Angeles California 90095 United States Details
Stanford California 94305 United States Details
Denver Colorado 80218 United States Details
Ocala Florida 34471 United States Details
Saint Petersburg Florida 33705 United States Details
Urbana Illinois 61801 United States Details
Boston Massachusetts 02111 United States Details
Boston Massachusetts 02114 United States Details
Rochester Minnesota 55905 United States Details
Saint Louis Missouri 63110 United States Details
Las Vegas Nevada 89135 United States Details
Buffalo New York 14263 United States Details
Durham North Carolina 27710 United States Details
Cleveland Ohio 44106 United States Details
Columbus Ohio 43210 United States Details
Philadelphia Pennsylvania 19111 United States Details
Pittsburgh Pennsylvania 15232 United States Details
Nashville Tennessee 37203 United States Details
Wenatchee Washington 98801 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field